RAPT Therapeutics, Inc. Operating Lease, Payments
RAPT Therapeutics, Inc. reported Operating Lease, Payments of $2.90 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow
us-gaap:OperatingLeasePayments · last filed 2025-03-06
- RAPT Therapeutics, Inc. operating lease, payments for the quarter ending 2023-12-31 was $700.00K, a 40.00% increase year-over-year.
- RAPT Therapeutics, Inc. operating lease, payments for the quarter ending 2023-09-30 was $700.00K, a 40.00% increase year-over-year.
- RAPT Therapeutics, Inc. operating lease, payments for the quarter ending 2023-06-30 was $700.00K, a 16.67% increase year-over-year.
- RAPT Therapeutics, Inc. operating lease, payments for the quarter ending 2023-03-31 was $600.00K, a 20.00% increase year-over-year.
- RAPT Therapeutics, Inc. operating lease, payments for fiscal 2024 was $2.90M, a 7.41% increase from fiscal 2023.
- RAPT Therapeutics, Inc. operating lease, payments for fiscal 2023 was $2.70M, a 28.57% increase from fiscal 2022.
- RAPT Therapeutics, Inc. operating lease, payments for fiscal 2022 was $2.10M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.90M 10-K · filed 2025-03-06 | |||
| 2023-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $1.40M derived: sum of 2 quarters · filed 2024-03-07 | $2.10M derived: sum of 3 quarters · filed 2024-03-07 | $2.70M 10-K · filed 2024-03-07 |
| 2023-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.40M derived: sum of 2 quarters · filed 2023-11-13 | $2.00M 10-Q · filed 2023-11-13 | $2.50M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.30M 10-Q · filed 2023-08-11 | $1.80M derived: sum of 3 quarters · filed 2023-08-11 | $2.30M derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $600.00K 10-Q · filed 2023-05-11 | $1.10M derived: sum of 2 quarters · filed 2023-05-11 | $1.60M derived: sum of 3 quarters · filed 2023-05-11 | $2.20M derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.00M derived: sum of 2 quarters · filed 2023-03-14 | $1.60M derived: sum of 3 quarters · filed 2023-03-14 | $2.10M 10-K · filed 2023-03-14 |
| 2022-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.10M derived: sum of 2 quarters · filed 2022-11-10 | $1.60M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.10M 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $500.00K 10-Q · filed 2022-05-11 |